Morris Financial Concepts’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1K Buy
90
+63
+233% +$10.8K 0.01% 174
2026
Q1
$4.56K Hold
27
﹤0.01% 184
2025
Q4
$4.56K Hold
27
﹤0.01% 181
2025
Q3
$3.9K Hold
27
﹤0.01% 187
2025
Q2
$3.42K Hold
27
﹤0.01% 188
2025
Q1
$3.45K Hold
27
﹤0.01% 188
2024
Q4
$3.57K Hold
27
﹤0.01% 172
2024
Q3
$3.93K Hold
27
﹤0.01% 177
2024
Q2
$3.71K Hold
27
﹤0.01% 150
2024
Q1
$3.71K Hold
27
﹤0.01% 153
2023
Q4
$3.67K Hold
27
﹤0.01% 150
2023
Q3
$3.3K Hold
27
﹤0.01% 139
2023
Q2
$3.43K Hold
27
﹤0.01% 141
2023
Q1
$3.49K Hold
27
﹤0.01% 135
2022
Q4
$3.54K Hold
27
﹤0.01% 127
2022
Q3
$3K Hold
27
﹤0.01% 104
2022
Q2
$3K Hold
27
﹤0.01% 111
2022
Q1
$4K Hold
27
﹤0.01% 106
2021
Q4
$4K Buy
+27
New +$4.18K ﹤0.01% 95

Other funds holding IBB

Morris Financial Concepts's IBB Position: Q2 2026 in Review

Morris Financial Concepts increased its iShares Biotechnology ETF (IBB) stake by 233% in Q2 2026, buying an estimated $10.8K and bringing the position to 90 shares worth $17.1K. The position accounts for 0.01% of the portfolio, ranked #174.

Morris Financial Concepts first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Morris Financial Concepts held 90 shares of iShares Biotechnology ETF worth $17.1K as of Q2 2026.
  • Morris Financial Concepts bought 63 iShares Biotechnology ETF shares in Q2 2026, an estimated $10.8K.
  • iShares Biotechnology ETF made up 0.01% of Morris Financial Concepts's portfolio in Q2 2026, its #174 holding.
  • Morris Financial Concepts first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Morris Financial Concepts's 13F filing for Q2 2026, filed 29 Jul 2026.